Zoetis Inc. Gain (Loss) on Disposition of Assets
Zoetis Inc. (ZTS) reported Gain (Loss) on Disposition of Assets of -$3.00 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-04.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2025-11-04
- Zoetis Inc. gain (loss) on disposition of assets for the quarter ending 2017-04-02 was $0.00, a 100.00% decline year-over-year.
- Zoetis Inc. gain (loss) on disposition of assets for the quarter ending 2016-12-31 was -$1.00M.
- Zoetis Inc. gain (loss) on disposition of assets for the quarter ending 2016-10-02 was $0.00.
- Zoetis Inc. gain (loss) on disposition of assets for the quarter ending 2016-07-03 was -$6.00M.
- Zoetis Inc. gain (loss) on disposition of assets for fiscal 2023 was $0.00.
- Zoetis Inc. gain (loss) on disposition of assets for fiscal 2022 was $0.00.
- Zoetis Inc. gain (loss) on disposition of assets for fiscal 2021 was -$3.00M, a 115.79% decline from fiscal 2020.
- Zoetis Inc. gain (loss) on disposition of assets for fiscal 2020 was $19.00M, a 5.00% decline from fiscal 2019.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$3.00M 10-Q · filed 2025-11-04 | |||
| 2024-09-30 | -$22.00M 10-Q · filed 2025-11-04 | |||
| 2023-12-31 | $0.00 10-K · filed 2024-02-13 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-02-13 | |||
| 2021-12-31 | -$3.00M 10-K · filed 2024-02-13 | |||
| 2020-12-31 | $19.00M 10-K · filed 2023-02-14 | |||
| 2019-12-31 | $20.00M 10-K · filed 2022-02-15 | |||
| 2018-12-31 | $40.00M 10-K · filed 2021-02-16 | |||
| 2017-12-31 | -$11.00M 10-K · filed 2020-02-13 | |||
| 2017-04-02 | $0.00 10-Q · filed 2017-05-04 | -$1.00M derived: sum of 2 quarters · filed 2019-02-14 | -$1.00M derived: sum of 3 quarters · filed 2019-02-14 | -$7.00M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | -$1.00M derived: sum of 2 quarters · filed 2019-02-14 | -$7.00M derived: sum of 3 quarters · filed 2019-02-14 | $26.00M 10-K · filed 2019-02-14 |
| 2016-10-02 | $0.00 10-Q · filed 2016-11-03 | -$6.00M derived: sum of 2 quarters · filed 2016-11-03 | $27.00M 10-Q · filed 2016-11-03 | $27.00M derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-07-03 | -$6.00M 10-Q · filed 2016-08-05 | $27.00M 10-Q · filed 2016-08-05 | $27.00M derived: sum of 3 quarters · filed 2017-05-04 | $27.00M derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-04-03 | $33.00M 10-Q · filed 2017-05-04 | $33.00M derived: sum of 2 quarters · filed 2017-05-04 | $33.00M derived: sum of 3 quarters · filed 2017-05-04 | $33.00M derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $0.00 derived: sum of 2 quarters · filed 2017-02-16 | $0.00 derived: sum of 3 quarters · filed 2017-02-16 | $0.00 10-K · filed 2017-02-16 |
| 2015-09-27 | $0.00 10-Q · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | $3.00M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-06-28 | $0.00 10-Q · filed 2016-08-05 | $0.00 10-Q · filed 2016-08-05 | $3.00M derived: sum of 3 quarters · filed 2017-02-16 | $3.00M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-03-29 | $0.00 10-Q · filed 2016-05-06 | $3.00M derived: sum of 2 quarters · filed 2017-02-16 | $3.00M derived: sum of 3 quarters · filed 2017-02-16 | $9.00M derived: sum of 4 quarters · filed 2017-02-16 |
| 2014-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $3.00M derived: sum of 2 quarters · filed 2017-02-16 | $9.00M derived: sum of 3 quarters · filed 2017-02-16 | $9.00M 10-K · filed 2017-02-16 |
| 2014-09-28 | $0.00 10-Q · filed 2015-11-05 | $6.00M derived: sum of 2 quarters · filed 2015-11-05 | $6.00M 10-Q · filed 2015-11-05 | |
| 2014-06-29 | $6.00M 10-Q · filed 2015-08-06 | $6.00M 10-Q · filed 2015-08-06 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $0.00 derived: sum of 2 quarters · filed 2016-02-24 | $6.00M derived: sum of 3 quarters · filed 2016-02-24 | $6.00M 10-K · filed 2016-02-24 |
| 2013-09-29 | $0.00 10-Q · filed 2014-11-10 | $6.00M derived: sum of 2 quarters · filed 2014-11-10 | $6.00M 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $6.00M 10-Q · filed 2014-08-12 | $6.00M 10-Q · filed 2014-08-12 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $0.00 derived: sum of 2 quarters · filed 2015-02-27 | $0.00 derived: sum of 3 quarters · filed 2015-02-27 | $0.00 10-K · filed 2015-02-27 |
| 2012-09-30 | $0.00 10-Q · filed 2013-11-13 | $0.00 derived: sum of 2 quarters · filed 2013-11-13 | $0.00 10-Q · filed 2013-11-13 | |
| 2012-07-01 | $0.00 10-Q · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | ||
| 2011-12-31 | $0.00 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |